Skip to main content
    I

    InMed Pharmaceuticals Inc (INM)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $1.33
    +0.02 (+1.53%)

    Market Cap: $7.20M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    57%(12/21)
    Avg Surprise
    -18.16%
    Streak
    1 Q
    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    Reported Sep 9
    		$-1.43N/AN/ABeat-19.5%
    Mar 26
    Reported May 6
    		$-0.73N/AN/ABeat+62.1%
    Dec 25
    Reported Feb 11
    		$-0.51N/AN/ABeat+85.9%
    Sep 25
    Reported Nov 6
    		$-0.44N/AN/ABeat-101.0%
    Jun 25
    Reported Sep 23
    		$-1.20N/AN/ABeat-452.2%
    Mar 25
    Reported May 12
    		$-1.94N/AN/ABeat-979.9%
    Dec 24
    Reported Feb 12
    		$-3.64N/AN/ABeat+74.0%
    Sep 24
    Reported Nov 14
    		$-0.22$0.00N/ABeat-113.7%
    Jun 24
    Reported Sep 27
    		$-0.22$0.00N/ABeat+93.3%
    Mar 24
    Reported May 14
    		$-0.18$-0.18+0.44%Beat+70.1%
    Dec 23
    Reported Feb 13
    		$-14.03$-5.50-155.09%Miss-1441.8%
    Sep 23
    Reported Nov 14
    		$-0.10N/A+53.77%Beat+99.9%
    Jun 23
    Reported Sep 29
    		$-3.25$-4.25+23.53%Beat+76.8%
    Mar 23
    Reported May 15
    		$-0.60N/A+86.67%Beat+99.6%
    Dec 22
    Reported Feb 17
    		$-0.91N/A+79.78%Beat+99.5%
    Sep 22
    Reported Nov 11
    		$-107.86$-108.50+0.59%Beat+30.6%
    Jun 22
    Reported Sep 23
    		$-14.03$-5.50-155.09%Miss-36.9%
    Mar 22
    Reported May 13
    		$-161.65$-159.50-1.35%Miss+21.1%
    Dec 21
    Reported Feb 14
    		$-197.45$-149.50-32.07%Miss-6.7%
    Sep 21
    Reported Nov 10
    		$-155.49$-222.00+29.96%Beat-45632.4%
    Jun 21
    Reported Sep 24
    		$-10.25$-8.50-20.59%Miss+99.1%
    Mar 21
    Reported May 13
    		$-205.00$-152.50-34.43%Miss+37.9%
    Dec 20
    Reported Feb 11
    		$-185.00$-153.50-20.52%Miss+43.9%
    Sep 20
    Reported Dec 17
    		$-0.34N/A+97.94%Beat+99.9%
    Jun 20
    Reported Sep 8
    		$-1105.00$-330.00-234.85%Miss-167324.2%
    Mar 20
    Reported May 14
    		$-330.00$-330.00+0.00%Beat+0.0%
    Dec 19
    Reported Feb 14
    		$-330.00$-330.00+0.00%Beat-84951.5%
    Sep 19
    Reported Nov 8
    		$-330.00$-330.00+0.00%Beat-78490.1%
    Jun 19
    Reported Sep 19
    		$-0.66$-0.66+0.00%Beat-32.3%
    Mar 19
    Reported May 15
    		$-330.00$-165.00-100.00%Miss-89965.5%
    Dec 18
    Reported Feb 12
    		$-0.39N/AN/ABeat-28.3%
    Sep 18
    Reported Nov 12
    		$-0.42N/AN/ABeat-14.7%
    Jun 18
    Reported Sep 13
    		$-0.50N/AN/ABeat+99.7%
    Mar 18
    Reported May 11
    		$-0.37N/AN/ABeat-34.8%
    Dec 17
    Reported Feb 22
    		$-0.30N/AN/ABeat-21.2%
    Sep 17
    Reported Oct 12
    		$-0.37N/AN/ABeat-
    Jun 17
    Reported Jun 30
    		$-180.36N/AN/ABeat-
    Mar 17
    Reported Apr 1
    		$-0.27N/AN/ABeat-
    Dec 16
    Reported Feb 27
    		$-0.25N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.43EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-156.80%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio1.37xQuick Ratio1.37x
    Trading Statistics
    Beta0.93Avg Volume57.30K
    52-Week High$2.3352-Week Low$0.57

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.33
    SMA 20$1.35
    SMA 50$1.38
    SMA 200$1.19
    EMA 10$1.34
    EMA 20$1.35
    EMA 50$1.38
    EMA 200$1.41

    MACD

    Line: -0.01Signal: -0.01Hist: 0.00

    ADX

    ADX: 25.6+DI: 22.0-DI: 14.7

    Aroon & PSAR

    Aroon Up20.0
    Aroon Down12.0
    PSAR$1.50

    Bollinger Bands

    Upper Band$1.40
    Lower Band$1.30
    %B Position744%(Upper)
    Band Width0.26

    RSI (14-Day)

    Neutral
    45.1

    Momentum Oscillators

    Stoch %K7.9
    Stoch %D15.5
    Williams %R-84.6
    ROC (10d)-1.5%
    Momentum-0.02
    CCI (20d)-114.0
    MFI (14d)36.9

    Volatility Measures

    ATR (14d)$0.06(4.5%)
    StdDev (20d)0.03
    Hist Vol20.9%(Moderate)

    Volume Flow

    VWAP$1.33
    OBV329.5M
    AD Line-154.9M
    CMF (20d)-0.434

    Volume Metrics

    Avg Vol (20d)44.4K
    Vol Ratio0.4x(Low)
    VWMA (20d)$1.36

    Pivot Points

    R3$1.39
    R2$1.38
    R1$1.34
    Pivot Point$1.33
    S1$1.29
    S2$1.28
    S3$1.24

    Advanced Oscillators

    TSI-9.62
    Ultimate Osc21.3
    KST-25.86

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$-1,940,309$0$820,188$1.12M$1.30M$0$1.11M$1.26M$1.28M$1.17M$1.24M$901,862
    Cost of Revenue$-1,352,956$0$635,994$716,962$728,056$0$650,813$771,225$816,996$883,143$916,058$880,620
    Gross Profit$-587,353$0$184,194$403,159$576,654$0$460,894$493,413$466,071$289,458$324,142$21,242
    Operating Expenses$4.32M$2.82M$2.30M$2.17M$2.42M$2.06M$2.67M$2.25M$2.48M$2.09M$2.03M$2.65M
    R&D$793,595$1.02M$630,636$581,612$112,720$425,370$895,176$700,145$658,869$656,764$609,791$1.29M
    SG&A$1.77M$1.74M$1.62M$1.53M$2.25M$1.58M$1.72M$1.49M$1.76M$1.37M$1.36M$1.30M
    Operating Income$-4,906,651$-2,816,353$-2,120,738$-1,763,670$-1,842,135$-2,061,469$-2,206,258$-1,754,272$-2,009,007$-1,796,168$-1,704,841$-2,624,414
    Interest Income$29,057$47,770$74,379$93,765$51,687$16,565$30,536$57,094$103,640$121,458$166,760$136,043
    Interest Expense$0$0$0$0$0$5,600$368,766$0$0$0$0$0
    Income Before Tax$-4,826,268$-2,791,751$-2,028,223$-1,726,899$-1,788,311$-2,067,069$-2,575,024$-1,677,868$-1,930,571$-1,722,866$-1,478,185$-2,536,828
    Income Tax Expense$0$0$0$0$0$0$0$0$7,100$0$0$0
    Net Income$-5,839,392$-2,966,336$-2,028,223$-1,726,899$-1,788,311$-2,120,930$-2,575,024$-1,677,868$-1,937,671$-1,722,866$-1,478,185$-2,536,828
    EBITDA$-4,576,990$-2,706,063$-1,962,719$-1,663,984$-2,290,952$-1,954,051$-2,476,481$-1,589,982$-1,820,429$-1,789,554$-1,589,714$-2,523,507
    EBIT$-4,837,189$-2,839,521$-2,120,738$-1,820,664$-2,422,034$-2,083,634$-2,605,560$-1,734,962$-1,972,290$-1,844,324$-1,644,945$-2,672,871
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about INM

    News

    Form 4 InMed Pharmaceuticals Inc.: ADAR1 Capital Management, LLC (10% Owner) For: 13 October By Investing.com

    This article reports on a Form 4 filing for InMed Pharmaceuticals Inc., indicating that ADAR1 Capital Management, LLC, a 10% owner...

    Investing.com South Africa•10/15/26•Neutral

    At $1.32–$1.33 a share, ADAR1 funds buy 9,569 shares of InMed Pharmaceuticals (INM).

    ADAR1 Capital Management LLC-managed funds acquired a total of 9,569 shares of InMed Pharmaceuticals (INM) between October 13 and October 15, 2026. The purchases were made at prices ranging from $1.32 to $1.33 per share...

    Stock Titan•10/15/26•Somewhat-Bullish

    ADAR1 Capital Management, LLC Adds 10,903 Shares of InMed Pharma

    ADAR1 Capital Management, LLC increased its stake in InMed Pharmaceuticals Inc. (INM) by purchasing 10,903 shares at $1.33 per share on October 8, 2026. This transaction brings their total holding to 945,924 shares...

    GuruFocus•10/15/26•Somewhat-Bearish

    Form 4 InMed Pharmaceuticals Inc. For: 12 October By Investing.com

    This article reports on a Form 4 filing for InMed Pharmaceuticals Inc. on October 12. It reiterates the filing information multiple times and includes a stock symbol for InMed (INM). The content also features various...

    Investing.com South Africa•10/12/26•Neutral

    Form 4 InMed Pharmaceuticals Inc. For: 12 October By Investing.com

    This article from Investing.com reports the filing of Form 4 by InMed Pharmaceuticals Inc. on October 12th. Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) by company...

    Investing.com India•10/12/26•Neutral

    INM Valuation and Fair Value

    P/E
    -0.4x
    P/B
    5.2x
    See GNG's fair value

    INM Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -156.8%

    INM Competitors

    CompanyTicker
    XWELL Inc.XWEL
    Predictive Oncology IncPOAI
    Soligenix Inc.SNGX
    Skye Bioscience, Inc. Common StockSKYE
    Aprea Therapeutics IncAPRE
    FibroBiologics, Inc. Common StockFBLG
    Senti Biosciences IncSNTI
    Nutriband Inc. WarrantNTRBW

    Sector: Healthcare

    INM Bull Case vs Bear Case

    Bear case

    • INM's quarterly revenue changed -26.2% year over year.

    INM Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    14.9%

    Frequently Asked Questions About INM

    Does INM pay dividends?

    InMed Pharmaceuticals Inc (INM) does not currently pay a regular dividend.

    What is INM's market cap?

    InMed Pharmaceuticals Inc (INM) has a market capitalization of $7.20M with a current stock price of $1.33.

    Related stocks

    Sector: Healthcare

    All stocks starting with I

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In